VRNA β€” VERONA PHARMA PLC

Ownership history in Frazier Life Sciences Management, L.P.  Β·  13 quarters on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
12.8% (2025 Q2)
πŸ“Š Avg. % of fund
5.31%
πŸ“… First filed
2022 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
13
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 3,383,950 β€” 0% 10.82% $361.1M β€”
2025 Q2 REDUCED 3,383,950 -73,900 -2.1% 12.80% $320.1M β€”
2025 Q1 ADDED 3,457,850 +73,900 +2.2% 10.03% $219.5M β€”
2024 Q4 UNCHANGED 3,383,950 β€” 0% 6.52% $157.2M β€”
2024 Q3 ADDED 3,383,950 +69,601 +2.1% 3.90% $97.4M β€”
2024 Q2 ADDED 3,314,349 +300,000 +10.0% 2.24% $47.9M β€”
2024 Q1 UNCHANGED 3,014,349 β€” 0% 2.05% $48.5M β€”
2023 Q4 UNCHANGED 3,014,349 β€” 0% 3.20% $59.9M β€”
2023 Q3 ADDED 3,014,349 +70,000 +2.4% 3.26% $49.1M β€”
2023 Q2 UNCHANGED 2,944,349 β€” 0% 3.72% $62.2M β€”
3 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding VRNA

As of 2025 Q3 β€” sorted by position size

SYQUANT CAPITAL SAS 3Y 37.01% Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48%
← Back to Frazier Life Sciences Management, L.P. Holdings